These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 28460186
1. cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells. Simo-Cheyou ER, Youreva V, Srivastava AK. Can J Physiol Pharmacol; 2017 Aug; 95(8):928-937. PubMed ID: 28460186 [Abstract] [Full Text] [Related]
10. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. Mottola G, Chatterjee A, Wu B, Chen M, Conte MS. PLoS One; 2017 Apr 01; 12(3):e0174936. PubMed ID: 28362840 [Abstract] [Full Text] [Related]
11. Cross-talk between angiotensin II and glucagon receptor signaling mediates phosphorylation of mitogen-activated protein kinases ERK 1/2 in rat glomerular mesangial cells. Li XC, Carretero OA, Zhuo JL. Biochem Pharmacol; 2006 Jun 14; 71(12):1711-9. PubMed ID: 16643859 [Abstract] [Full Text] [Related]
12. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3. Taurin S, Hogarth K, Sandbo N, Yau DM, Dulin NO. J Biol Chem; 2007 Jul 06; 282(27):19518-25. PubMed ID: 17513863 [Abstract] [Full Text] [Related]
13. Increasing cAMP antagonizes hypertrophic response to angiotensin II without affecting Ras and MAP kinase activation in vascular smooth muscle cells. Takahashi T, Kawahara Y, Okuda M, Yokoyama M. FEBS Lett; 1996 Nov 11; 397(1):89-92. PubMed ID: 8941720 [Abstract] [Full Text] [Related]
14. Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Liu GC, Oudit GY, Fang F, Zhou J, Scholey JW. Am J Physiol Renal Physiol; 2012 Mar 15; 302(6):F784-90. PubMed ID: 22189944 [Abstract] [Full Text] [Related]
15. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells. Naviglio S, Di Gesto D, Illiano F, Chiosi E, Giordano A, Illiano G, Spina A. J Cell Physiol; 2010 Nov 15; 225(3):801-9. PubMed ID: 20589829 [Abstract] [Full Text] [Related]
16. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells. Kimura TE, Duggirala A, Hindmarch CC, Hewer RC, Cui MZ, Newby AC, Bond M. J Mol Cell Cardiol; 2014 Jul 15; 72(100):9-19. PubMed ID: 24534707 [Abstract] [Full Text] [Related]
17. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells. Cospedal R, Lobo M, Zachary I. Biochem J; 1999 Sep 01; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028 [Abstract] [Full Text] [Related]
18. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization. Gros R, Ding Q, Chorazyczewski J, Pickering JG, Limbird LE, Feldman RD. Circ Res; 2006 Oct 13; 99(8):845-52. PubMed ID: 16973907 [Abstract] [Full Text] [Related]
19. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K. Torella D, Gasparri C, Ellison GM, Curcio A, Leone A, Vicinanza C, Galuppo V, Mendicino I, Sacco W, Aquila I, Surace FC, Luposella M, Stillo G, Agosti V, Cosentino C, Avvedimento EV, Indolfi C. Am J Physiol Heart Circ Physiol; 2009 Dec 13; 297(6):H2015-25. PubMed ID: 19783773 [Abstract] [Full Text] [Related]
20. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Won SM, Park YH, Kim HJ, Park KM, Lee WJ. Exp Mol Med; 2006 Oct 31; 38(5):525-34. PubMed ID: 17079869 [Abstract] [Full Text] [Related] Page: [Next] [New Search]